Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Jul 21:4:11.
doi: 10.1186/1476-7961-4-11.

Specific antibodies to recombinant allergens of Aspergillus fumigatus in cystic fibrosis patients with ABPA

Viswanath P Kurup  1 , Alan P Knutsen, Richard B Moss, Naveen K Bansal
Affiliations

Specific antibodies to recombinant allergens of Aspergillus fumigatus in cystic fibrosis patients with ABPA

Viswanath P Kurup et al. Clin Mol Allergy. .

Abstract

Background: Aspergillus fumigatus, a widely distributed fungus, has been implicated in causing life threatening infections as well as severe asthma and allergic diseases in man. Allergic affliction like allergic bronchopulmonary aspergillosis (ABPA) is a disabling lung disease frequently seen in patients with asthma and cystic fibrosis. Immunodiagnosis of the former is comparatively easier due to the availability of purified antigens and sensitive methods. However, this is not true with cystic fibrosis patients where the prevalence of ABPA is fairly high and the morbidity and mortality are significant.

Methods: In the present study, we have evaluated purified recombinant allergens from A. fumigatus, namely Asp f 1, f 2, f 3, f 4, and f 6 using ELISA and a semi-automated method (ImmunoCAP). We studied 17 patients each from cystic fibrosis with ABPA, and cystic fibrosis with asthma, 22 cystic fibrosis with no ABPA or asthma, and 11 age matched controls.

Results: The results indicate that no antigen, antibody or method is capable of differentiating cystic fibrosis (CF) with ABPA from other CF patients, although some allergens showed strong reaction or showed more prevalence among the patients studied.

Conclusion: When results of several allergens such as Asp f 1, f 2, f 3, f 4, and f 6 in their binding to IgA, IgG, and IgE antibodies were analyzed, a more strong discrimination of CF patients with ABPA was possible from the other groups studied.

PubMed Disclaimer

Figures

Figure 1
Figure 1
IgE antibodies against various recombinant allergens and crude Aspergillus extract. A. IgE measured by ImmunoCAP. B. IgE measured by ELISA.
Figure 2
Figure 2
IgA, IgA1, IgA2, IgG1, IgG2, IgG3, and IgG4 antibodies against crude Aspergillus fumigatus antigens and various recombinant allergens. A – A. fumigatus extract, B – Asp f 1, C – Asp f 2, D – Asp f 3, E – Asp f 4, and F – Asp f 16.
Figure 3
Figure 3
Scatter plot showing discriminant function analysis using IgE, IgA, and IgG antibody responses against Asp f 1, f 2, f 3, f 4, and f 6. Two different functions were analyzed and the results indicate good discrimination of the different groups. ■ normals, formula image CF, X CF with atopy, ▲CF-ABPA patients, and □ the centroids of each group.
See this image and copyright information in PMC

References

    1. Greenberger PA. Allergic bronchopulmonary aspergillosis. In: Adkinson NF, Jr, Yunginger JW, Busse WW, Bochner BS, Holgate ST, Simons FER, editor. Middleton's Allergy, Principles and Practices. 2. Philadelphia: Mosby; 2003. pp. 1353–1371.
    1. Kurup VP, Apter AJ. Immunology and Allergy Clinics of North America. Philadelphia: WB Saunders Company; 1998.
    1. Stevens DA, Moss R, Kurup VP, Knutsen AP, Greenberger P, Judson MA, Denning DW, Crameri R, Brody AS, Light M, Skov M, Maish W, Mastella G, participants in the Cystic Fibrosis Foundation Consensus Conference Allergic bronchopulmonary aspergillosis in cystic fibrosis-state of the art: Cystic fibrosis foundation consensus conference. Clin Infect Dis. 2003;37:S225–S264. doi: 10.1086/376525. - DOI - PubMed
    1. Greenberger PA. Diagnosis and management of allergic bronchopulmonary aspergillosis. Allergy Proc. 1994;15:335–339. - PubMed
    1. Becker JW, Burke W, McDonald G, Greenberger PA, Henderson WR, Atiken ML. Prevalence of allergic bronchopulmonary aspergillosis and atopy in adult patients with cystic fibrosis. Chest. 1996;109:1536–1540. - PubMed

LinkOut - more resources